Managing Partner, General Counsel and Owner, The Bliss Group; Chair, Bliss Bio Health

Michael Roth, Esq.

New York, NY

Michael is a Founder and Managing Partner at the Bliss Group, a 50-year-old insight-driven marketing communications agency that blends data science with the art of storytelling to target priority audiences with precision, empathy, and purpose. Michael moved from a senior position at Real Chemistry (W2O/Twist) to build an integrated (B2B and B2C) healthcare practice at Bliss.  The business of health group is now the largest integrated vertical at the agency. Michael also serves as Chair of Bliss Bio Health (BBH), a global health group designed to unite strategies for clients, embrace and effectively implement new technologies, and facilitate fully integrated and innovative communications, marketing, public affairs, and advertising programs. CTRx, an innovative clinical trial recruitment platform under the BBH umbrella, was founded by Michael Roth and Colin Foster (TNP) in 2020.   

Before joining Bliss in 2012, Michael held executive positions on both the agency and client side at Novartis Corporation, GCI/ Grey Advertising (WPP), Real Chemistry, and his own boutique agency, BMC Communications. His diverse experience ranges from hands-on leadership and management of marketing communication campaigns for blockbuster brands (e.g., Nexium, Lexapro) to strategic oversight of Fortune 500 issues management and corporate reputation campaigns. Michael is a lawyer (J.D.) and member of the NY and NJ State Bar Associations. He is a lifelong jazz/rock musician, having toured and recorded with mostly insignificant bands, and collects vintage 1960s keyboards. He resides in Irvington, New York with his wife Mary, 22-year-old twins Ella Jane and Sam Coltrane and his dogs Phoebe and Clyde.  

Q & A

I was pretty much formed and perfect by the age of 15. Next question.

There are so many, but my top project in the last 5 years has been working with Johns Hopkins, DoD, and NIH on clinical trial enrollment for a natural COVID treatment. In the process we began to teach CTR at Hopkins, showed the WHO that they were wrong about convalescent plasma, developed our own CTRx clinical trial offering, and became a published NEJM trial author, along with my marketing colleague Colin Foster.

Same as a great colleague — they are true partners, valuing mutual respect, trust, and chemistry. They listen as much as they speak. It’s a back and forth based on respect.

See previous answer.

My family is almost everything to me. But I have been playing music since I was five years old in both a professional and amateur capacity. I still take piano lessons every Friday (chasing after the brains of Parker, Davis, Coltrane, Monk), and play in rock and jazz bands — sometimes at clubs. One day I hope to own a jazz club where I will happily lose of all my money.